BioCardia, Inc. (BCDA)

BioCardia Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	0.47	0.48	1.35	1.02	0.15	0.71
Revenue Growth (YoY)	-65.49%	-64.72%	33.20%	600.00%	-79.58%	13.60%
Cost of Revenue	6.58	7.73	8.83	8.56	9.81	8.92
Gross Profit	-6.12	-7.25	-7.48	-7.54	-9.67	-8.21
Selling, General & Admin	4.29	4.4	4.42	5.09	5.86	6
Operating Expenses	4.29	4.4	4.42	5.09	5.86	6
Operating Income	-10.41	-11.64	-11.9	-12.63	-15.53	-14.21
Interest Expense	-	-	-	-	-0	-0.11
Interest & Investment Income	0.07	0.07	-	-	0.02	0.09
Other Non Operating Income (Expenses)	-0	-	-0.01	0.01	-0	-0
EBT Excluding Unusual Items	-10.34	-11.57	-11.91	-12.62	-15.51	-14.24
Other Unusual Items	-	-	-	-	0.51	-0.47
Pretax Income	-10.34	-11.57	-11.91	-12.62	-15	-14.71
Net Income	-10.34	-11.57	-11.91	-12.62	-15	-14.71
Net Income to Common	-10.34	-11.57	-11.91	-12.62	-15	-14.71
Shares Outstanding (Basic)	1	1	1	1	1	0
Shares Outstanding (Diluted)	1	1	1	1	1	0
Shares Change (YoY)	21.19%	19.52%	4.75%	67.19%	79.27%	32.37%
EPS (Basic)	-6.92	-8.19	-10.08	-11.19	-22.24	-39.09
EPS (Diluted)	-6.92	-8.19	-10.08	-11.19	-22.24	-39.09
Free Cash Flow	-8.95	-9.99	-10.63	-10.48	-12.39	-9.59
Free Cash Flow Per Share	-5.99	-7.07	-9.00	-9.29	-18.37	-25.49
Operating Margin	-2224.15%	-2441.09%	-880.25%	-1244.33%	-10709.66%	-2001.83%
Free Cash Flow Margin	-1911.54%	-2093.50%	-786.32%	-1032.71%	-8544.14%	-1350.85%
EBITDA	-10.33	-11.56	-11.82	-12.57	-15.46	-14.1
D&A For EBITDA	0.08	0.08	0.08	0.06	0.07	0.11
EBIT	-10.41	-11.64	-11.9	-12.63	-15.53	-14.21
Revenue as Reported	0.48	0.48	1.35	1.02	0.15	0.71

Source: S&P Capital IQ. Standard template.